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Abstract 
Purpose: To evaluate the effects of ebracteolatain A (EA) and ebracteolatain B (EB) from Euphorbia 
ebracteolata Hyata (Euphorbiaceae) on the proliferation of HepG2 cells and the possible mechanisms. 
Methods: EA and EB from E. ebracteolata were obtained by column chromatography. 3-(4,5-
Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and flow cytometry assays were used to 
study the cytotoxic and pro-apoptotic activities of EA and EB against HepG2 cells. Western blot assay 
was used to investigate the possible mechanisms of action. 
Results: EA and EB were successfully isolated from E. ebracteolata by column chromatography. The 
results of MTT assay indicate that EA and EB have significant anti-proliferative activities against HepG2 
cells in dose- and time-dependent manners with half maximal inhibitory concentration (IC50) of 28.48 
and 31.72 μg/mL. respectively. The results of flow cytometry assay suggest that EA and EB significantly 
(p < 0.01) induced the apoptosis of HepG2 cells at the levels of 47.45 and 42.26 %, respectively. 
Western blot data indicate that EA and EB significantly (p < 0.05 or 0.01) down-regulated the expression 
levels of anti-apoptotic proteins (survivin and Bcl-2) and up-regulated the expression levels of pro-
apoptotic proteins (Smac, Bax, c-caspase-3 and c-caspase-9) in mitochondria-mediated apoptotic 
pathway. 
Conclusion: EA and EB inhibit the proliferation of HepG2 cells, the probable mechanisms being 
associated with mitochondria-mediated apoptosis. 
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Euphorbia ebracteolata Hyata (Euphorbiaceae) 
is cultivated in Japan, Korea and China [1] and 
its dried roots, named “Lang Du”, are usually 
used to treat ascites, edema, chronic tracheitis, 
pulmonary tuberculosis and cancer [2]. Currently, 
a few researches have reported the anti-cancer 
activities of E. ebracteolata [3-6]. It is reported 
that the water extract of E. ebracteolata induces 
the apoptosis of P388 lymphocytic leukemia cells 
by regulating the expression levels of Bax and 
Bcl-2 [3]. The 2, 4-dihydroxy-6-methoxy-3-
methylacetophenone from E. ebracteolata has 
significant inhibitory effect on the growth of U14 
cervical cancer cells [4]. Yuexiandajisu D from E. 
ebracteolata inhibits the proliferation of HCT-8, 
KB, A549, Bel-7402 and BGC-823 cells [5]. 
Jolkinolide B and ent-11α-hydroxyabieta-
8(14),13(15)-dien-16,12α-olide from E. 
ebracteolata show cytotoxicity activities against 
ANA-1, B16 and Jurkat cells [6]. In addition, the 
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terpenoids from Euphorbia L. show cytotoxic 
activities against SMMC-7221, L342, MCc80-3, 
U937 and HeLa cells, and their anti-cancer 
mechanisms may be related to apoptosis [7,8]. 
 
Ebracteolatain A (EA) and ebracteolatain B (EB) 
from E. ebracteolata are phloroglucinol 
derivatives. Phloroglucinol derivatives such as 
dryofragin and 2,4-bis(2-fluorophenylacetyl) 
phloroglucinol exhibits anti-cancer effects [9-11]. 
Based on these reports, we supposed that EA 
and EB may have anti-cancer effects. In this 
work, we used 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT), and flow 
cytometry assays to investigate the effect of EA 
and EB on the proliferation and apoptosis of 
HepG2 cells in vitro by determining their 
inhibition rates and apoptosis rates. Moreover, 
the Western blot assay was used to explore the 






The roots of E. ebracteolata were obtained from 
Zhong Yao Cai Tian Di Internet (www.zyctd.com) 
in March 2013, which were identified by Gang 
Peng from Suizhou Hospital, Hubei University of 
Medicine. A voucher specimen (Herbarium No. 
201303154) of this plant is stored in Hubei 
University of Medicine for future reference. 
 
Analytical grade reagents (petroleum, 
chloroform, n-butyl alcohol and methanol), silica 
gel, preparative TLC and Sephadex LH-20 were 
provided by Qingdao Haiyang Chemical Co., Ltd. 
(Qingdao, China) or H&E Co., Ltd. (Beijing, 
China). Fetal bovine serum (FBS) and RPMI-
1640 medium were provided by Invitrogen 
(Carlsbad, CA, USA). MTT and DMSO were 
provided by Sigma (MO, USA). Enhanced BCA 
Protein Assay Kit and Annexin V-FITC/PI 
apoptosis assay kit were provided by Beyotime 
(Shanghai, China) and BD Bioscience (San 
Diego, CA, USA), respectively. β-actin, survivin, 
Bcl-xl, Bcl-2, Smac, Bax, cleaved-caspase-3 (c-
caspase-3), cleaved-caspase-9 (c-caspase-9) 
antibodies and horseradish peroxidase (HRP)-
conjugated goat anti-rabbit antibody were 
purchased form Cell Signaling Technology 
(Beverly, MA, USA) and Abcam Biotechnology 
(Cambridge, MA, USA). 
 
Isolation of EA and EB 
 
The air-dried roots (10 kg) of E. ebracteolata 
were smashed and extracted thrice with 95 % 60 
L of ethanol. After filtering, the combined ethanol 
solution was evaporated by rotary evaporator 
under high vacuum to obtain ethanol extract 
(1357 g), which was suspended in water and 
subsequently partitioned with petroleum, 
chloroform and n-butyl alcohol. The chloroform 
fraction (234 g) was subjected to 200 - 300 mesh 
silica gel column chromatography eluting with 
chloroform-methanol (19:1, 9:1, 7:3, 5:5) to 
obtain 7 fractions. Fraction 2 (17.5 g) was 
subjected to Sephadex LH-20 column 
chromatography eluting with chloroform-
methanol (5:5) to obtain EA (121 mg). Fraction 6 
(10.3 g) was separated on 200-300 mesh silica 
gel column and preparative TLC to obtain EB (53 
mg). The chemical structures and purities of EA 
and EB were identified and analyzed by nuclear 
magnetic resonance (NMR) and high 




HepG2 cells were provided by American Type 
Culture Collection (ATCC, Manassas, VA, USA). 
According to the existing literature [12], HepG2 
cells were cultured in RPMI-1640 medium 
supplemented with 10 % FBS, penicillin (100 
U/mL) and streptomycin (100 U/mL) at 37 °C in 5 
% CO2/95 % air. HepG2 cells were sub-cultured 
to logarithmic phase of growth, and then assays 
were carried out on the re-cultured HepG2 cells. 
 
Cell proliferation assay 
 
The effects of EA and EB on the proliferation of 
HepG2 cells were evaluated using MTT assay 
according to the existing literature [13]. Briefly, 
HepG2 cells were seeded onto 96 well cell 
culture plates at 5000/well and incubated for 24 h 
at 37 °C [14]. Then HepG2 cells were treated 
with EA or EB at different concentrations of 0, 5, 
10, 15, 20, 25, 30, 35, 40, 45 and 50 μg/mL for 
48 h or at same concentrations of 30 μg/mL for 
0, 12, 24, 36 and 48 h. After treatments, 20 μL 
MTT solution (5 mg/mL, dissolved in PBS) was 
added into each well incubated at 37 °C in 5 % 
CO2/95 % air for another 3 h to generate purple-
blue formazan precipitate. Subsequently, DMSO 
(200 μL) was added into each well to dissolve 
the purple-blue formazan precipitate and the 
optical density (OD) of the DMSO solution was 
measured at 570 nm in a microplate reader (Bio 
Rad, Model 680). The inhibition rates were used 
to assess the effects of EA and EB on the 
proliferation of HepG2 cells and calculated using 
the following equation:  
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Inhibition rate (%) = (OD control – OD treatment)/OD 
control × 100. 
 
Flow cytometry analysis 
 
After treatment with EA or EB at concentration of 
30 μg/mL for 48 h, HepG2 cells were harvested 
and washed thrice with PBS. Subsequently, the 
washed HepG2 cells were re-suspended and 
stained with Annexin V-FITC/PI, and then 
analyzed by flow cytometer according to the 
manufacturer’s instructions. The early apoptotic 
cells were a kind of Annexin V-FITC-positivity 
and PI-negativity cells, and the late apoptotic 
cells were a kind of Annexin V-FITC-positivity 
and PI-positivity cells [15]. The numbers of 
apoptotic cells were calculated as the total 
numbers of the early and late apoptotic cells in 
flow cytometry. 
 
Western blot analysis 
 
HepG2 cells were collected to extract total 
proteins after treatment with EA or EB at different 
concentrations of 15, 30 and 45 μg/mL for 48 h. 
The Enhanced BCA Protein Assay Kit was used 
to determine the concentration of total proteins. 
Then equal amounts of total proteins (about 40 
μg) were separated on 12 % sodium dodecyl 
sulfate/polyacrylamide gel electrophoresis 
(SDS/PAGE) and blotted on PVDF membrane. 
After blocking with 5 % fat-free milk in Tris 
buffered saline-Tween (TBS-T), the PVDF 
membranes were incubated with primary 
antibodies including anti-β-actin, anti-Survivin, 
anti-Bcl-xl, anti-Bcl-2, anti-Smac, anti-Bax, anti-c-
caspase-3, anti-cleaved c-caspase-9 overnight at 
4 °C, followed by incubation with HRP-
conjugated secondary antibody for 1 h at room 
temperature. Chemiluminescence detection was 
used to detect all proteins. To assess the 
proteins loading, β-actin was selected as the 
internal control, and the expression levels of 





The results are presented as mean ± standard 
deviation (SD) (n=3). Differences between 
different groups were analyzed by one-way 
ANOVA (Dunnett test) on SPSS 19.0. P-value 








Identifications and purities analysis of EA 
and EB 
 
The target analytes were identified as EA and EB 
by comparing their NMR data with the literature 
[1] and their chemical structures are shown in 
Figure 1. The results of HPLC area normalization 
method indicated that the purity levels of EA and 
EB were 93.0 % and 92.8 %, respectively. 
 
EA: 1H-NMR (400 MHz, CDCl3) δ: 6.24 (1H, s, H-
5), 3.75 (3H, s, H-2-OMe), 2.48 (3H, s, H-3-Ar), 
2.52 (3H, s, H-3'-Ac), 3.78 (3H, s, H-4'-OMe), 
1.89 (3H, s, H-5'- CH3), 3.62 (2H, s, H-Ar-CH2-
Ar); 13C-NMR (100 MHz, CDCl3) δ: 105.3 (C-1), 
156.5 (C-2), 105.2 (C-3), 162.7 (C-4), 92.5 (C-5), 
163.1 (C-6), 55.8 (C-2-OMe), 33.1 (C-3-Ac), 
204.7 (C-3-Ac), 111.1 (C-1'), 162.5 (C-2'), 107.9 
(C-3'), 163.5 (C-4'), 111.4 (C-5'), 160.4 (C-6'), 
31.7 (C-3'-Ac), 202.4 (C-3'-Ac), 64.7 (C-4'-OMe), 
8.3 (C-5'-CH3), 16.5 (C-Ar-CH2-Ar). 
 
EB: 1H-NMR (400 MHz, pyridine-d5) δ: 2.47 (3H, 
s, H-1-Ac), 5.78 (2H, s, H-5', 5"), 3.21 (6H, s, H-
4', 4"-OMe), 2.18 (6H, s, H-3', 3"-Ac), 4.03 (4H, 
s, H-Ar-CH2-Ar); 13C-NMR (100 MHz, pyridine-d5) 
δ: 103.4 (C-1), 161.5 (C-2), 108.2 (C-3), 170.8 
(C-4), 108.2 (C-5), 161.5 (C-6), 32.6 (C-1-Ac), 
201.4 (C-1-Ac), 108.9 (C-1', 1"), 164.6 (C-2', 2"), 
105.6 (C-3', 3"), 161.9 (C-4', 4"), 93.4 (C-5', 5"), 
166.7 (C-6', 6"), 55.0 (C-4', 4"-OMe), 32.3 (C-3', 
3"-Ac), 204.1 (C-3', 3"-Ac), 17.6 (C-Ar-CH2-Ar). 
 
Effects of EA and EB on the proliferation of 
HepG2 cells 
 
As shown in Figure 2, after treatment with EA or 
EB at different concentrations of 0, 5, 10, 15, 20, 
25, 30, 35, 40, 45 and 50 μg/mL for 48 h, the 
proliferation of HepG2 cells was significantly 
inhibited in dose-dependent manner and their 
half maximal inhibitory concentration (IC50) 
values were 28.48 and 31.72 μg/mL, 
respectively. After treatment with EA or EB at 
same concentration of 30 μg/mL for 0, 12, 24, 36 
and 48 h, the proliferation of HepG2 cells was 
significantly inhibited in time-dependent manner. 
 
HepG2 cells apoptosis induced by EA and EB 
 
The results of flow cytometry analysis (Figure 3) 
suggested that after treatment with EA or EB at 
concentration of 30 μg/mL for 48 h, the apoptosis 
of HepG2 cells were significantly (p < 0.01) 
induced, compared with the control, and their 
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apoptosis rates were 47.45 and 42.26 %, 
respectively. 
EA and EB regulate the expression levels of 
apoptotic proteins 
 
As depicted in Figures 4 and 5, EA and EB had 
similar effects on the expression levels of these 
apoptotic proteins (Survivin, Bcl-xl, Bcl-2, Smac, 
Bax, c-caspase-3 and c-caspase-9). After 
treatment with EA or EB at different 
concentrations of 15, 30 and 45μg/mL for 48 h, 
the expression levels of anti-apoptotic proteins 
(Survivin and Bcl-2) were significantly (p < 0.01) 
down-regulated and the expression levels of pro-
apoptotic proteins (Smac, Bax, c-caspase-3 and 
c-caspase-9) were significantly (p < 0.01 or 0.05) 
up-regulated, compared with the control, 
whereas the expression level of anti-apoptotic 




Many study reports [3-6] have confirmed that E. 
ebracteolata can be used to treat cancer. In the 
present study, we studied the effects of EA and 
EB from E. ebracteolata on the proliferation of 
HepG2 cells and the possible mechanisms in 
vitro by MTT, flow cytometry and Western blot 
assays. The results showed that EA and EB 
inhibited the proliferation of HepG2 cells by 
inducing apoptosis via mitochondria-mediated 
apoptotic pathway. 
 
MTT, a yellow dye, interacts with 
succinodehydrogenase (SDH) derived from 
mitochondria of living cells to generate the 
purple-blue formazan precipitate, but dead cells 
do not have the function [13]. Then formazan 
precipitate was dissolved in DMSO and the OD 
value of the DMSO solution was used to evaluate 
cell viability. The smaller the OD value is, the 
lower the cell viability is. Based on the theory, 
MTT assay is usually used to evaluate the effects 
of anticancer agents on proliferation of cancer 
cells [16]. The results of MTT assay (Figure 2) 
suggested that EA and EB significantly inhibited 
the proliferation of HepG2 cells. 
 
The externalization of phosphatidylserine (PS) is 
observed in early apoptotic cells and the Annexin 
V can combine with the external PS. PI can 
combine with cell nucleus through the cell 
membrane in late apoptotic cells. After early or 
late apoptotic cells were stained with Annexin V-
FITC/PI, they can be analyzed by flow cytometry 
[17]. The results of flow cytometry analysis 
(Figure 3) indicated that EA and EB induced the 
apoptosis of HepG2 cells. The results of MTT 
assay and flow cytometry analysis indicated that 
the anti-proliferative activities of EA and EB are 
associated with apoptosis. 
 
 
Figure 1: Chemical structures of ebracteolatain A (EA) and ebracteolatain B (EB) 
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Figure 2: Inhibitory effects of ebracteolatain A (EA) and ebracteolatain B (EB) on the proliferation of HepG2 cells 
 
 
Figure 3: Effects of ebracteolatain A (EA) and ebracteolatain B (EB) on the apoptosis of HepG2 cells; **p < 0.01, 
vs control 
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Figure 4: Effects of ebracteolatain A (EA) on the expression levels of anti-apoptotic proteins (Survivin, Bcl-xl and 




Figure 5: Effects of ebracteolatain B (EB) on the expression levels of anti-apoptotic proteins (Survivin, Bcl-xl and 
Bcl-2) and pro-apoptotic proteins (Smac, Bax, c-caspase-3 and c-caspase-9); *p < 0.05, **p < 0.01, vs control 
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Mitochondria-mediated apoptosis is an important 
pathway that is used to induce the apoptosis of 
cells, and the apoptotic proteins (Bid, Bax, Bcl-2, 
Smac, survivin, cytochrome c, caspase-9 and 
caspase-3) play an important role in 
mitochondria-mediated apoptotic pathway 
[18,19]. When cells are stimulated by apoptotic 
stimuli, mitochondria will make a series of 
responses to reply the apoptotic stimuli. Firstly, 
the releases of Smac and cytochrome c from 
mitochondria to cytoplasm are up-regulated [20], 
but the releases are inhibited by Bcl-2, whose 
function can be suppressed by Bax and Bid [21]. 
Secondly, cytochrome c along with dATP, Apaf-1 
and pro-caspase-9 form apotosome and then 
procaspase-9 is activated to generate c-caspase-
9 [22]. Subsequently, caspase-3 is activated by 
c-caspase-9 to generate c-caspase-3 which 
induces the apoptosis of cells [23]. Meanwhile, 
survivin inhibits the generation and function of c-
caspase-3 [24]. However, the inhibitory effect of 
survivin is eliminated by Smac [25]. The results 
of western blot assay (Figures 4 and 5) indicated 
that EA and EB significantly down-regulated the 
expression levels of anti-apoptotic proteins 
(Survivin and Bcl-2) and up-regulated the 
expression levels of pro-apoptotic proteins 
(Smac, Bax, c-caspase-3 and c-caspase-9) 
without effect on the expression level of anti-
apoptotic protein (Bcl-xl), indicating that the pro-
apoptotic mechanisms of EA and EB in HepG2 





The findings of this study indicate that EA and 
EB inhibit the proliferation of HepG2 cells and the 
possible mechanisms are associated with 
mitochondria-mediated apoptosis. The results 
also provide evidence to support the 
ethnomedical use of E. ebracteolata for the 
treatment of cancer and as a potential source of 
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